Precision BioSciences, Inc.
DTIL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $26,034 | $42,064 | $104,598 | $434,292 |
| - Cash | $85,899 | $116,678 | $189,576 | $143,663 |
| + Debt | $30,045 | $31,268 | $27,036 | $9,113 |
| Enterprise Value | -$29,820 | -$43,346 | -$57,942 | $299,742 |
| Revenue | $68,696 | $48,727 | $25,098 | $115,529 |
| % Growth | 41% | 94.1% | -78.3% | – |
| Gross Profit | $68,696 | $48,727 | $25,098 | $115,529 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $13,526 | -$32,042 | -$62,794 | -$20,273 |
| % Margin | 19.7% | -65.8% | -250.2% | -17.5% |
| Net Income | $7,167 | -$61,319 | -$111,637 | -$30,602 |
| % Margin | 10.4% | -125.8% | -444.8% | -26.5% |
| EPS Diluted | 1.04 | -15.96 | -38.1 | -15.6 |
| % Growth | 106.5% | 58.1% | -144.2% | – |
| Operating Cash Flow | -$58,445 | -$84,114 | -$45,753 | -$10,853 |
| Capital Expenditures | -$250 | -$2,278 | -$3,319 | -$5,803 |
| Free Cash Flow | -$58,695 | -$86,392 | -$49,072 | -$16,656 |